Our objective is to improve the care of patients with malignant disease through: A. investigation of new modalities and optimal utilization of already available modalities, alone and in combination; B. provision of opportunities for study and training in approaches to the problems of patients with cancer; C. and provision of service to patients with malignant diseases. This will be accomplished within the framework of the Southwest Oncology Group whose purposes are: A. to conduct clinical therapeutic trials in patients with neoplastic diseases; B. to report the results of these trials; C. to conduct research which may more generally influence the field of oncology; D. to play an educational role within and beyond the Group.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
Application #
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Tulane University
Schools of Medicine
New Orleans
United States
Zip Code
Rivkin, Saul E; Green, Stephanie J; Lew, Danika et al. (2003) Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of Cancer 97:21-9
Saiki, J H; Stuckey, W J; Athens, J W et al. (1993) Mitoxantrone (dihydroxyanthracenedione) in acute leukemia. An evaluation of two treatment schedules by the Southwest Oncology Group. Invest New Drugs 11:197-200
Stuckey, W J; Crowley, J; Baker, L H et al. (1987) Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study. Cancer Treat Rep 71:1095-6
Morgan, J E; McCaul, D S; Rodriguez, F H et al. (1987) Pulmonary immunologic features of alveolar septal amyloidosis associated with multiple myeloma. Chest 92:704-8
Tranum, B L; Dixon, D; Quagliana, J et al. (1987) Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a Southwest Oncology Group Study. Cancer Treat Rep 71:643-4
Harvey, W H; Fleming, T R; Beltran, G et al. (1987) Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study. Cancer Treat Rep 71:1111-2
Abernathy, D; Beltran, G; Stuckey, W J (1986) Lung cancer following treatment for lymphoma. Am J Med 81:215-8
Temple, J J; Andes, W A (1986) AIDS and Hodgkin's disease. Lancet 2:454-5
Dabich, L; Bull, F E; Beltran, G et al. (1986) Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study. Cancer Treat Rep 70:967-9
Dana, B W; Jones, S E; Coltman, C et al. (1986) Salvage treatment of unfavorable non-Hodgkin's lymphoma with cisplatin, amsacrine, and mitoguazone: a Southwest Oncology Group Pilot Study. Cancer Treat Rep 70:291-2

Showing the most recent 10 out of 13 publications